Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis have?
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis has 691 citations in the OpenAlex counts ScholarIQ stores.
When was Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis published?
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis has 2018 year in the ScholarIQ index.
What is the open-access status of Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis?
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis has hybrid oa status in the ScholarIQ index.
What is the DOI of Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis?
The DOI for Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis is on the source record.
What is the PMID of Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis?
The PMID for Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis is on the source record.
What is the OpenAlex record for Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis?
The OpenAlex for Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis is on the source record.